...
机译:靶向TGF-β的溶瘤腺病毒增强了间皮素靶向嵌合抗原受体T细胞疗法的抗肿瘤反应对乳腺癌
Jilin Univ Sch Nursing 965 Xinjiang St Changchun 130021 Jilin Peoples R China;
Beijing Inst Radiat Med Dept Expt Hematol Beijing 100850 Peoples R China;
Weifang Heart Dis Hosp Dept Pathol Weifang 261206 Peoples R China;
Jilin Univ Sch Nursing 965 Xinjiang St Changchun 130021 Jilin Peoples R China;
Jilin Univ Sch Nursing 965 Xinjiang St Changchun 130021 Jilin Peoples R China;
Jilin Univ Sch Nursing 965 Xinjiang St Changchun 130021 Jilin Peoples R China;
Jilin Univ Sch Nursing 965 Xinjiang St Changchun 130021 Jilin Peoples R China;
Univ Chicago NorthShore Res Inst Gene Therapy Program Dept Med Evanston IL 60201 USA;
Beijing Inst Radiat Med Dept Expt Hematol Beijing 100850 Peoples R China;
Beijing Inst Radiat Med Dept Expt Hematol Beijing 100850 Peoples R China;
Jilin Univ Sch Nursing 965 Xinjiang St Changchun 130021 Jilin Peoples R China;
Chimeric antigen receptor modified T cells; Oncolytic adenovirus; Mesothelin; Transforming growth factor; Breast cancer;
机译:靶向TGF-β的溶瘤腺病毒增强了间皮素靶向嵌合抗原受体T细胞疗法的抗肿瘤反应对乳腺癌
机译:Ard oncolytic腺病毒表达PD-L1迷你体增强了嵌合抗原受体T细胞在实体瘤中的抗肿瘤作用
机译:MUC1-TN靶向嵌合抗原受体改性的Vγ9Vδ2T细胞,具有增强的抗原特异性抗肿瘤活性
机译:提高嵌合抗原受体T细胞治疗肿瘤治疗疗效的主要问题及目前策略
机译:优化嵌合抗原受体(汽车)T细胞通过IL-36γ进行增强和扩大的抗肿瘤免疫应答
机译:表达PD-L1微型抗体的武装溶瘤腺病毒增强嵌合抗原受体T细胞在实体瘤中的抗肿瘤作用
机译:新型培养基配方增强嵌合抗原受体(轿厢)T细胞效力和抗肿瘤细胞函数用于采用免疫疗法